Skip to main content

EyePoint, Inc. (EYPT)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.30
As of

Kresmion compiles this page from EYPT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

EyePoint, Inc. (EYPT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-12.

As of . Source: SEC EDGAR filings for EYPT. Method and limitations.

COMPANY DOSSIER

See the full EYPT dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for EYPT on one page. Preview it with sample data, then open it live with a free account.

Preview the EYPT dossier

Active events for EYPT

FREE, NO ACCOUNT

Every event on EYPT, as it fires

You are seeing 5 of 15 events recorded on EYPT since 2026-06-03.

The five above landed across 3 days. The other 10 were recorded on 4 other days. 9 of the 15 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, EYPT

Going concern statement

EYPT's 10-Q filed Nov 12, 2026 states:

These conditions and events raise substantial doubt about the Company's ability to continue as a going concern.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on EYPT

EYPT mentioned in Kresmion daily briefs

EYPT against its peers

EYPT's net margin of -739.4% ranks in the 42nd percentile of 5 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-07-31.

MetricEYPTPeer medianPercentilen
Revenue FY31.4M USD254795 USD948
Operating margin-776.0%n/an/a4
Net margin-739.4%-594.6%425
Return on equity-75.8%-81.4%5014
1 yearn/a-65.4%n/a15

Peers (18): IMMP, ACET, AARD, MGX, PMN, EDSA, BRNS, ABVC, BYSI, CVM, ALGS, RNAZ, QNCX, LITS, CELU, NXTC, NNVC, BCTX. Left out: EVAX (no annual filing), PLRZ (no annual filing), MDNAF (no annual filing), TTIPF (no annual filing), SEOVF (no annual filing), RLFTY (no annual filing), ZIVO (period gap). Fiscal periods ending between 2025-06-30 and 2026-07-31. Every figure is one full fiscal year read from one annual filing (EYPT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in EYPT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on EYPT in the last 180 days.

Upstream: SEC EDGAR filings for EYPT

Kresmion, "EyePoint, Inc. (EYPT) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/EYPT. Upstream data: SEC EDGAR filings for EYPT.

Link to this data (HTML):

<a href="https://kresmion.com/research/EYPT">EyePoint, Inc. (EYPT) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow EYPT on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to EYPT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the EYPT dossier
Share

The EYPT intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.